Importance of diabetes management during the COVID-19 pandemic
Open Access
- 4 October 2021
- journal article
- review article
- Published by Taylor & Francis Ltd in Postgraduate Medicine
- Vol. 133 (8), 912-919
- https://doi.org/10.1080/00325481.2021.1978704
Abstract
Uncontrolled diabetes and/or hyperglycemia is associated with severe COVID-19 disease and increased mortality. It is now known that poor glucose control before hospital admission can be associated with a high risk of in-hospital death. By achieving and maintaining glycemic control, primary care physicians (PCPs) play a critical role in limiting this potentially devastating outcome. Further, despite the hope that mass vaccination will help control the pandemic, genetic variants of the virus are causing surges in some countries. As such, PCPs will treat an increasing number of patients with diabetes who have symptoms of post–COVID-19 infection, or even have new-onset type 2 diabetes as a result of COVID-19 infection. However, much of the literature published focuses on the effects of COVID-19 in hospitalized patients, with few publications providing information and advice to those caring for people with diabetes in the primary care setting. This manuscript reviews the current knowledge of the risk and outcomes of individuals with diabetes who are infected with COVID-19 and provides information for PCPs on the importance of glucose control, appropriate treatment, and use of telemedicine and online prescription delivery systems to limit the potentially devastating effects of COVID-19 in people with hyperglycemia.Keywords
Funding Information
- Sanofi US
This publication has 59 references indexed in Scilit:
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?The Lancet Respiratory Medicine, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational StudyDiabetes Therapy, 2020
- Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient’s perspective. The EnREDa2 StudyBMJ Open, 2019
- Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2018
- Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetesCardiovascular Diabetology, 2015
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMCNature, 2013
- Use of telemedicine in subjects with type 1 diabetes equipped with an insulin pump and real-time continuous glucose monitoringJournal of Telemedicine and Telecare, 2012
- Infections in patients with diabetes mellitus: A review of pathogenesisIndian Journal of Endocrinology and Metabolism, 2012
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetesActa Diabetologica, 2009